Literature DB >> 18600344

Epac activation, altered calcium homeostasis and ventricular arrhythmogenesis in the murine heart.

Sandeep S Hothi1, Iman S Gurung, Jennifer C Heathcote, Yanmin Zhang, Stephen W Booth, Jeremy N Skepper, Andrew A Grace, Christopher L-H Huang.   

Abstract

The recently described exchange protein directly activated by cAMP (Epac) has been implicated in distinct protein kinase A-independent cellular signalling pathways. We investigated the role of Epac activation in adrenergically mediated ventricular arrhythmogenesis. In contrast to observations in control conditions (n = 20), monophasic action potentials recorded in 2 of 10 intrinsically beating and 5 of 20 extrinsically paced Langendorff-perfused wild-type murine hearts perfused with the Epac activator 8-pCPT-2'-O-Me-cAMP (8-CPT, 1 microM) showed spontaneous triggered activity. Three of 20 such extrinsically paced hearts showed spontaneous ventricular tachycardia (VT). Programmed electrical stimulation provoked VT in 10 of 20 similarly treated hearts (P < 0.001; n = 20). However, there were no statistically significant accompanying changes (P > 0.05) in left ventricular epicardial (40.7 +/- 1.2 versus 44.0 +/- 1.7 ms; n = 10) or endocardial action potential durations (APD(90); 51.8 +/- 2.3 versus 51.9 +/- 2.2 ms; n = 10), transmural (DeltaAPD(90)) (11.1 +/- 2.6 versus 7.9 +/- 2.8 ms; n = 10) or apico-basal repolarisation gradients, ventricular effective refractory periods (29.1 +/- 1.7 versus 31.2 +/- 2.4 ms in control and 8-CPT-treated hearts, respectively; n = 10) and APD(90) restitution characteristics. Nevertheless, fluorescence imaging of cytosolic Ca(2+) levels demonstrated abnormal Ca(2+) homeostasis in paced and resting isolated ventricular myocytes. Epac activation using isoproterenol in the presence of H-89 was also arrhythmogenic and similarly altered cellular Ca(2+) homeostasis. Epac-dependent effects were reduced by Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) inhibition with 1 microM KN-93. These findings associate VT in an intact cardiac preparation with altered cellular Ca(2+) homeostasis and Epac activation for the first time, in the absence of altered repolarisation gradients previously implicated in reentrant arrhythmias through a mechanism dependent on CaMKII activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18600344      PMCID: PMC3714550          DOI: 10.1007/s00424-008-0508-3

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  60 in total

1.  Protein kinase A phosphorylation at serine-2808 of the cardiac Ca2+-release channel (ryanodine receptor) does not dissociate 12.6-kDa FK506-binding protein (FKBP12.6).

Authors:  Bailong Xiao; Cindy Sutherland; Michael P Walsh; S R Wayne Chen
Journal:  Circ Res       Date:  2004-01-08       Impact factor: 17.367

Review 2.  Cellular basis of triggered arrhythmias in heart failure.

Authors:  Steven M Pogwizd; Donald M Bers
Journal:  Trends Cardiovasc Med       Date:  2004-02       Impact factor: 6.677

Review 3.  Cell physiology of cAMP sensor Epac.

Authors:  George G Holz; Guoxin Kang; Mark Harbeck; Michael W Roe; Oleg G Chepurny
Journal:  J Physiol       Date:  2006-09-14       Impact factor: 5.182

Review 4.  Ventricular fibrillation: how do we stop the waves from breaking?

Authors:  J N Weiss; P S Chen; Z Qu; H S Karagueuzian; A Garfinkel
Journal:  Circ Res       Date:  2000-12-08       Impact factor: 17.367

Review 5.  Epac proteins: multi-purpose cAMP targets.

Authors:  Johannes L Bos
Journal:  Trends Biochem Sci       Date:  2006-11-02       Impact factor: 13.807

6.  Electrical alternans and vulnerability to ventricular arrhythmias.

Authors:  D S Rosenbaum; L E Jackson; J M Smith; H Garan; J N Ruskin; R J Cohen
Journal:  N Engl J Med       Date:  1994-01-27       Impact factor: 91.245

7.  cAMP analog mapping of Epac1 and cAMP kinase. Discriminating analogs demonstrate that Epac and cAMP kinase act synergistically to promote PC-12 cell neurite extension.

Authors:  Anne E Christensen; Frode Selheim; Johan de Rooij; Sarah Dremier; Frank Schwede; Khanh K Dao; Aurora Martinez; Carine Maenhaut; Johannes L Bos; H-G Genieser; Stein O Døskeland
Journal:  J Biol Chem       Date:  2003-06-20       Impact factor: 5.157

8.  Arrhythmogenic mechanisms in a mouse model of catecholaminergic polymorphic ventricular tachycardia.

Authors:  Marina Cerrone; Sami F Noujaim; Elena G Tolkacheva; Arkadzi Talkachou; Ryan O'Connell; Omer Berenfeld; Justus Anumonwo; Sandeep V Pandit; Karen Vikstrom; Carlo Napolitano; Silvia G Priori; José Jalife
Journal:  Circ Res       Date:  2007-09-13       Impact factor: 17.367

9.  Pharmacological separation of early afterdepolarizations from arrhythmogenic substrate in DeltaKPQ Scn5a murine hearts modelling human long QT 3 syndrome.

Authors:  G Thomas; M J Killeen; A A Grace; C L-H Huang
Journal:  Acta Physiol (Oxf)       Date:  2007-10-31       Impact factor: 6.311

10.  Nifedipine and diltiazem suppress ventricular arrhythmogenesis and calcium release in mouse hearts.

Authors:  Richard Balasubramaniam; Sangeeta Chawla; Lauren Mackenzie; Christof J Schwiening; Andrew A Grace; Christopher L-H Huang
Journal:  Pflugers Arch       Date:  2004-07-30       Impact factor: 3.657

View more
  35 in total

Review 1.  Regulation of the inflammatory response of vascular endothelial cells by EPAC1.

Authors:  Euan Parnell; Brian O Smith; Timothy M Palmer; Anna Terrin; Manuela Zaccolo; Stephen J Yarwood
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

2.  Ventricular arrhythmogenesis following slowed conduction in heptanol-treated, Langendorff-perfused mouse hearts.

Authors:  Gary Tse; Sandeep S Hothi; Andrew A Grace; Christopher L-H Huang
Journal:  J Physiol Sci       Date:  2012-01-05       Impact factor: 2.781

3.  Epac2-dependent mobilization of intracellular Ca²+ by glucagon-like peptide-1 receptor agonist exendin-4 is disrupted in β-cells of phospholipase C-ε knockout mice.

Authors:  Igor Dzhura; Oleg G Chepurny; Grant G Kelley; Colin A Leech; Michael W Roe; Elvira Dzhura; Parisa Afshari; Sundeep Malik; Michael J Rindler; Xin Xu; Youming Lu; Alan V Smrcka; George G Holz
Journal:  J Physiol       Date:  2010-11-01       Impact factor: 5.182

4.  β-Adrenergic induced SR Ca2+ leak is mediated by an Epac-NOS pathway.

Authors:  Laëtitia Pereira; Dan J Bare; Samuel Galice; Thomas R Shannon; Donald M Bers
Journal:  J Mol Cell Cardiol       Date:  2017-05-02       Impact factor: 5.000

5.  Novel Epac fluorescent ligand reveals distinct Epac1 vs. Epac2 distribution and function in cardiomyocytes.

Authors:  Laëtitia Pereira; Holger Rehmann; Dieu Hung Lao; Jeffrey R Erickson; Julie Bossuyt; Ju Chen; Donald M Bers
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-17       Impact factor: 11.205

6.  Epac enhances excitation-transcription coupling in cardiac myocytes.

Authors:  Laetitia Pereira; Gema Ruiz-Hurtado; Eric Morel; Anne-Coline Laurent; Mélanie Métrich; Alejandro Domínguez-Rodríguez; Sandra Lauton-Santos; Alexandre Lucas; Jean-Pierre Benitah; Donald M Bers; Frank Lezoualc'h; Ana M Gómez
Journal:  J Mol Cell Cardiol       Date:  2011-10-29       Impact factor: 5.000

Review 7.  Intracellular cAMP Sensor EPAC: Physiology, Pathophysiology, and Therapeutics Development.

Authors:  William G Robichaux; Xiaodong Cheng
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

8.  Early effects of Epac depend on the fine-tuning of the sarcoplasmic reticulum Ca2+ handling in cardiomyocytes.

Authors:  N Lezcano; J I E Mariángelo; L Vittone; X H T Wehrens; M Said; C Mundiña-Weilenmann
Journal:  J Mol Cell Cardiol       Date:  2017-10-14       Impact factor: 5.000

Review 9.  Beta-adrenergic receptor signaling in the heart: role of CaMKII.

Authors:  Michael Grimm; Joan Heller Brown
Journal:  J Mol Cell Cardiol       Date:  2009-10-31       Impact factor: 5.000

Review 10.  Myofibroblast-mediated mechanisms of pathological remodelling of the heart.

Authors:  Karl T Weber; Yao Sun; Syamal K Bhattacharya; Robert A Ahokas; Ivan C Gerling
Journal:  Nat Rev Cardiol       Date:  2012-12-04       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.